Verition Fund Management
NNVC icon

Verition Fund Management’s NanoViricides NNVC Stock Holding History

Verition Fund Management’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13,003
Closed -$22.4K – 3420
2024
Q2 		$22.4K Buy
+13,003
New +$23.2K ﹤0.01% 2860
2016
Q2 		– Sell
-936
Closed -$41K – 996
2016
Q1 		$41K Buy
+936
New +$36.3K 0.01% 685

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Verition Fund Management's NNVC Position: Q3 2024 in Review

Verition Fund Management sold out of NanoViricides (NNVC) in Q3 2024, closing a stake of 13,003 shares — an estimated $22.4K sold.

Verition Fund Management first reported a position in NNVC in Q1 2016 and held it in 2 quarters. The position peaked at $41K in Q1 2016. 32 funds tracked by Wall St. Rank hold NNVC as of Q3 2024.

  • Verition Fund Management reported no remaining NanoViricides position as of Q3 2024 after selling out during the quarter.
  • Verition Fund Management sold 13,003 NanoViricides shares in Q3 2024, an estimated $22.4K.
  • Verition Fund Management first reported a position in NanoViricides in Q1 2016 and held it in 2 quarters.
  • Verition Fund Management's NanoViricides position peaked at $41K in Q1 2016.
  • 32 funds tracked by Wall St. Rank held NanoViricides as of Q3 2024.

Based on Verition Fund Management's 13F filing for Q3 2024, filed 14 Nov 2024.